Condition 101 content is not available at this time, but we are continually updating the site. Please check back.

However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.

  • Condition: Accelerated Phase of Atypical Chronic Myeloid Leukemia (aCML) with Severe Disseminated Intravascular Coagulation
  • Journal: Internal medicine (Tokyo, Japan)
  • Treatment Used: Induction Chemotherapy
  • Number of Patients: 1
  • Published —
This case report describes a 38-year-old man diagnosed with hyperleukocytosis (high white blood cells) with dysplastic myeloid precursor cells and severe disseminated intravascular coagulation who had a hematopoietic recovery with features of atypical chronic myeloid leukemia (aCML) after induction chemotherapy.
  • Condition: Philadelphia-Negative Myeloproliferative Neoplasms (MPN) in Pregnancy
  • Journal: British journal of haematology
  • Treatment Used: Aspirin, Venesection, Low Molecular Weight Heparin (LMWH) and Cytoreductive Therapy
  • Number of Patients: 0
  • Published —
This article updated management strategies for Philadelphia-negative myeloproliferative neoplasms in pregnancy.
Clinical Trial
  • Status: Recruiting
  • Phase: Phase 2
  • Intervention Type: Procedure, Drug, Other
  • Participants: 32
  • Start Date: February 15, 2021
Phase II Study of a Geriatric Assessment-Driven, Risk-Adapted Allogeneic Hematopoietic Cell Transplant Strategy for Older Patients With Myeloid Malignancies
Clinical Trial
  • Status: Recruiting
  • Phase: Phase 1/Phase 2
  • Intervention Type: Drug
  • Participants: 40
  • Start Date: February 27, 2019
A Phase I/II Study of Azacitidine, Venetoclax and Pevonedistat in Adults With Newly Diagnosed Secondary or Therapy-Related AML